KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Change in Intangibles (2022 - 2023)

ClearPoint Neuro's Change in Intangibles history spans 2 years, with the latest figure at $167000.0 for Q4 2023.

  • On a quarterly basis, Change in Intangibles fell 22.33% to $167000.0 in Q4 2023 year-over-year; TTM through Dec 2024 was $167000.0, a 50.0% decrease, with the full-year FY2023 number at $334000.0, down 62.6% from a year prior.
  • Change in Intangibles hit $167000.0 in Q4 2023 for ClearPoint Neuro, roughly flat from $167000.0 in the prior quarter.
  • Over the last five years, Change in Intangibles for CLPT hit a ceiling of $562000.0 in Q3 2022 and a floor of $116000.0 in Q1 2022.